Latest Breaking News On - Hannah mamuszka - Page 1 : comparemela.com

Breast Cancer Risk: Testing To Tailored Screening, Treatment, and Prevention

Breast Cancer Risk: Testing To Tailored Screening, Treatment, and Prevention
ricochet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ricochet.com Daily Mail and Mail on Sunday newspapers.

Hannah mamuszkaJoe selvaggiRicochet audio network superfeedHub wonkApple podcasts

Hannah Mamuszka – Ricochet

Hannah Mamuszka – Ricochet
ricochet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ricochet.com Daily Mail and Mail on Sunday newspapers.

Hannah mamuszkaJoe selvaggi

BTIG Research Raises Bionano Genomics (NASDAQ:BNGO) Price Target to $10 00

Bionano Genomics (NASDAQ:BNGO – Free Report) had its price target hoisted by BTIG Research to $10.00 in a report released on Thursday morning, Marketbeat.com reports. BTIG Research currently has a buy rating on the stock. Separately, LADENBURG THALM/SH SH cut their price objective on Bionano Genomics from $60.00 to $48.00 in a report on Wednesday, […]

Hannah mamuszkaSecurities exchange commissionRenaissance technologiesBionano genomics incKokusai asset management coVanguard group incMitsubishi ufjBionano genomicsFree reportDirector hannah mamuszkaExchange commissionAsset managementAsset management gmbhStreet corpVanguard groupGet free report

Bionano Genomics, Inc (NASDAQ:BNGO) Sees Large Decrease in Short Interest

Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totalling 48,120,000 shares, a drop of 19.5% from the June 15th total of 59,800,000 shares. Based on an average trading volume of 10,440,000 shares, the short-interest ratio is currently 4.6 […]

Hannah mamuszkaChristopherp stewartFinancial groupBionano genomics company profileBrinker capital investmentsVerition fund managementLazard asset managementSecurities exchange commissionBionano genomics incSorce advisoryBionano genomicsGet free reportDirector hannah mamuszkaExchange commissionCapital investmentsAsset management

Insider Buying: Bionano Genomics, Inc (NASDAQ:BNGO) Director Buys 65,789 Shares of Stock

Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) Director Hannah Mamuszka bought 65,789 shares of the stock in a transaction on Tuesday, June 13th. The shares were acquired at an average cost of $0.76 per share, for a total transaction of $49,999.64. Following the purchase, the director now owns 65,789 shares in the company, valued at […]

Hannah mamuszkaArete wealth advisorsJpmorgan chase coGeode capital managementBionano genomics incBionano genomics company profileBionano genomicsGet ratingDirector hannah mamuszkaGenomics trading downState equity partnersWealth advisorsStreet corpCapital managementBionano genomics dailyNasdaq bngo